Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


September 01, 2015 4:17 AM ET

Pharmaceuticals

Company Overview of Allergan Inc.

Executive Profile

Scott M. Whitcup M.D.

Chief Scientific Officer and Executive Vice President of Research & Development, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
56$6,735,725
As of Fiscal Year 2014

Background

Dr. Scott M. Whitcup, M.D. has been the Chief Scientific Officer of Allergan Inc. since April 2009 and has also been its Executive Vice President of Research and Development since July 28, 2004. Dr. Whitcup is responsible for Allergan's drug discovery efforts as well as the ophthalmology, Botox(R)/neurology, skin care and new technology development programs worldwide. He joined Allergan in January 2000 as Vice President of Development and Ophthalmology. He served as ...

Corporate Headquarters

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships

Director
Director

Education

Bachelor's Degree
Cornell University
MD
Weill Cornell Medical College, New York

Other Affiliations

Annual Compensation

Salary$661,807
Total Annual Compensation$661,807

Stocks Options

Restricted Stock Awards$1,928,130
All Other Compensation$34,360
Exercised Options$108,200
Exercised Options Value$6,856,030
Exercisable Options$311,900
Exercisable Options Value$46,527,202
Unexercisable Options$192,315
Unexercisable Options Value$21,353,969
Total Value of Options$74,737,200
Total Number of Options$612,415

Total Compensation

Total Annual Cash Compensation$1,243,967
Total Short Term Compensation$661,807
Other Long Term Compensation$1,962,490
Total Calculated Compensation$6,735,725
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Allergan Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.